Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients
JA Morris, JE Hanson, BJ Steffen, AH Chu, KS Chi-Burris, VP Gotz, RD GordonVolume:
19
Year:
2005
Language:
english
Pages:
6
DOI:
10.1111/j.1399-0012.2005.00344.x
File:
PDF, 88 KB
english, 2005